Medi Assist Healthcare Services Ltd
Incorporated in June 2000, Medi Assist Healthcare Services Limited is a health-tech and insurance-tech company that manages health benefits for employers, retail members, and public health schemes, primarily serving insurance companies.[1]
- Market Cap ₹ 3,007 Cr.
- Current Price ₹ 404
- High / Low ₹ 594 / 385
- Stock P/E 62.3
- Book Value ₹ 35.1
- Dividend Yield 0.00 %
- ROCE 20.0 %
- ROE 14.3 %
- Face Value ₹ 5.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 65.7 days to 39.9 days
Cons
- Stock is trading at 11.5 times its book value
- Promoter holding is low: 4.62%
- Company has a low return on equity of 14.0% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Insurance Insurance Distributors
Part of BSE Allcap BSE Financial Services
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 53 | 62 | 54 | 55 | 64 | 108 | 151 | 204 | |
| 27 | 27 | 42 | 41 | 60 | 71 | 91 | 127 | |
| Operating Profit | 25 | 35 | 12 | 13 | 3 | 38 | 59 | 77 |
| OPM % | 48% | 56% | 22% | 25% | 5% | 35% | 39% | 38% |
| -11 | 25 | 45 | 14 | 22 | -1 | 8 | 10 | |
| Interest | 0 | 1 | 3 | 0 | 0 | 0 | 4 | 3 |
| Depreciation | 6 | 10 | 11 | 8 | 6 | 12 | 19 | 20 |
| Profit before tax | 8 | 49 | 43 | 18 | 19 | 26 | 45 | 64 |
| Tax % | 49% | 24% | 18% | -2% | 12% | 24% | 25% | |
| 4 | 37 | 35 | 18 | 17 | 19 | 33 | 48 | |
| EPS in Rs | 1,127.42 | 10,246.54 | 9,413.98 | 2.69 | 2.41 | 2.77 | 4.71 | 6.75 |
| Dividend Payout % | 0% | 0% | 0% | 70% | 78% | 90% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 40% |
| TTM: | 47% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | 26% |
| TTM: | -4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 14% |
| Last Year: | 14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.04 | 0.04 | 0.04 | 34 | 34 | 35 | 35 | 35 |
| Reserves | 79 | 76 | 164 | 133 | 133 | 181 | 194 | 226 |
| 52 | 78 | 6 | 5 | 3 | 1 | 15 | 13 | |
| 61 | 61 | 38 | 23 | 27 | 35 | 86 | 67 | |
| Total Liabilities | 192 | 215 | 208 | 195 | 198 | 252 | 331 | 342 |
| 21 | 23 | 16 | 10 | 23 | 17 | 64 | 70 | |
| CWIP | 3 | 1 | 1 | 6 | 0 | 3 | 4 | 0 |
| Investments | 75 | 88 | 94 | 103 | 95 | 133 | 120 | 83 |
| 94 | 104 | 97 | 76 | 79 | 99 | 143 | 188 | |
| Total Assets | 192 | 215 | 208 | 195 | 198 | 252 | 331 | 342 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 18 | -14 | 24 | -8 | 24 | 40 | 63 | |
| -21 | -0 | 28 | -4 | 7 | -49 | -49 | |
| 0 | -2 | -3 | -19 | -15 | 0 | -12 | |
| Net Cash Flow | -2 | -16 | 50 | -32 | 16 | -9 | 2 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 266 | 59 | 207 | 239 | 73 | 52 | 58 |
| Inventory Days | |||||||
| Days Payable | |||||||
| Cash Conversion Cycle | 266 | 59 | 207 | 239 | 73 | 52 | 58 |
| Working Capital Days | -315 | -378 | 91 | 240 | 77 | 80 | 40 |
| ROCE % | 34% | 25% | 9% | 11% | 25% | 20% |
Documents
Announcements
-
Disclosure Of Key Performance Indicators Under SEBI (Issue Of Capital And Disclosure Requirements) Regulations, 2018
1h - Q3 FY2025-26 KPIs: Revenue ₹6,627.81m, Adj. EBITDA ₹1,263.48m, PAT ₹462.94m; Premium ₹192,891m.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
1h - No deviation; Rs.198.00 crore preferential issue; Rs.148.40 crore utilized; balance Rs.49.60 crore invested.
-
Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue For The Quarter Ended December 31, 2025 And Monitoring Agency Report Issued By CARE Ratings Limited
2h - Raised Rs.198.00 crore (Oct 10, 2025); Rs.148.40 crore utilized; no deviation; monitoring report.
-
Approval Of Re-Classification Request By The Board Under SEBI Listing Regulations
2h - Feb 6, 2026: Board approved re-classification of six promoter entities to public; no shares held; pending exchange approvals.
-
Announcement under Regulation 30 (LODR)-Change in Management
2h - Chief Innovation and Operations Officer Himanshu Rastogi resigned effective close of business February 6, 2026.
Annual reports
Concalls
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptAI SummaryPPT
-
Sep 2024Transcript PPT
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
Business Profile[1] Company provides third-party administration (TPA) services to insurance companies through its wholly-owned Subsidiaries, Medi Assist TPA, Medvantage TPA, and Raksha TPA. A third-party administrator is an organization that processes health insurance claims for insurance companies and provides services such as policy administration, customer service, and network management, among others.